TMCnet News
Research and Markets: World Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Pipeline Review, H2 2015 - 43 Companies & 40 Drug ProfilesResearch and Markets (http://www.researchandmarkets.com/research/qsvsgv/plaque_psoriasis) has announced the addition of the "Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Plaque Psoriasis (Psoriasis Vulgaris), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with the latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Plaque Psoriasis (Psoriasis Vulgaris) and special features on late-stage and discontinued projects. The report enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development
For more information visit http://www.researchandmarkets.com/research/qsvsgv/plaque_psoriasis.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151214006208/en/ |
